Routine use of the 7-valent pneumococcal conjugate vaccine in infants beginning 11 years ago prevented an estimated 211,000 serious pneumococcal infections and 13,000 deaths during 2000–2008, including those among both children and adults. The switch to PCV13 in 2010 is expected to further reduce disease by covering those extra six strains, particularly 19A. The vaccination of adults aged 50 and older will expand that protection. Once PCV13 is approved for adults aged 50 and older, physicians in that age range should get the vaccine.
▸ Human Papillomavirus. Recommended for all previously unvaccinated women through age 26 years, Gardasil or Cervarix should be considered by all young female physicians. Moreover, although not a strict recommendation, Gardasil (but not Cervarix) is also suggested for men through age 26 years in order to reduce the likelihood of acquiring genital warts. The risk is particularly increased among men who have sex with men. There are physicians who fall into the above categories.
▸ Zoster. The zoster vaccine (Zostavax) is recommended for the prevention of shingles in all adults aged 60 years and older, including physicians.
Physician, vaccinate thyself.